Evidence map›Paper›PMID 40487584›Full record

ArticleNeuro-oncology practice2025

An evidence-based framework for postoperative surveillance of meningioma.

Brittany Owusu-Adjei, Jeewoo C Lim, Connie C Hou, Constance J Mietus, Rrita Daci, William Lambert, Hanya Qureshi, Bethany C Berry, Madison R B Marasco, Umika Paul and 2 more

Abstract read
In one paragraph

Article in Neuro-oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Brittany Owusu-AdjeiUMass Memorial Health, Worcester, Massachusetts, US.ORCID https://orcid.org/0009-0009-3695-3173
Jeewoo C LimUMass Memorial Health, Worcester, Massachusetts, US.
Connie C HouDepartment of Neurological Surgery, University of Massachusetts Chan Medical School, Worcester, Massachusetts, US.
Constance J MietusUMass Memorial Health, Worcester, Massachusetts, US.
Rrita DaciUMass Memorial Health, Worcester, Massachusetts, US.
William LambertUMass Memorial Health, Worcester, Massachusetts, US.
Hanya QureshiUMass Memorial Health, Worcester, Massachusetts, US.
Bethany C BerryDepartment of Neurological Surgery, University of Massachusetts Chan Medical School, Worcester, Massachusetts, US.
Madison R B MarascoDepartment of Neurological Surgery, University of Massachusetts Chan Medical School, Worcester, Massachusetts, US.
Umika PaulDepartment of Neurological Surgery, University of Massachusetts Chan Medical School, Worcester, Massachusetts, US.
Rachael W SirianniDepartment of Neurological Surgery, University of Massachusetts Chan Medical School, Worcester, Massachusetts, US.
Mark D JohnsonUMass Memorial Health, Worcester, Massachusetts, US.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Meningiomas frequently recur after surgery. Existing guidelines for postoperative surveillance are based on customary practices or limited data. This may result in excessive or inadequate surveillance. Methods: We compared 8 studies involving 1519 resected meningiomas with postoperative follow-up ranging from 7 to 23 years. Meningiomas were stratified using the World Health Organization and Simpson grading systems, and progression-free survival data were compared. Recurrence patterns were validated using 2 additional studies involving 2463 meningiomas. Results: Incompletely resected meningiomas of all grades displayed recurrences throughout the observation period. The 5-year and 10-year cumulative incidence of recurrence for completely resected Grade 1 meningiomas was 10% and 20%, with no recurrences beyond 11 years. For completely resected Grade 2 meningiomas, the 5-year and 10-year cumulative incidence of recurrence was 24% and 50%, with ongoing recurrences throughout the observation period. Elevated recurrence rates for Grade 1/2 meningiomas persisted beyond 5 years. For completely resected Grade 3 meningiomas, the 5-year cumulative incidence of recurrence was 63%, and all recurred before 10 years. Conclusions: Postoperative magnetic resonance imaging (MRI) at 48 h to determine the extent of resection and at 4 months to detect rapid regrowth is recommended. For completely resected Grade 1 meningiomas, annual MRI followed by discontinuation of surveillance if there is no recurrence after 11 years is reasonable. For completely resected Grade 2 meningiomas, annual MRI indefinitely is recommended. For Grade 3 meningiomas, MRI every 3-4 months for 2 years, followed by every 6 months indefinitely, is recommended. Incompletely resected meningiomas should be followed indefinitely.

Indexed as

follow-upmeningiomarecommendationsrecurrencesurveillance

Identifiers

PMID40487584
PMCPMC12137216

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.